Loading
Latest filing published 02 Jul 2024 for Medicine Man Technologies, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Paul Joseph Montalbano (board member) discloses dealings in Medicine Man Technologies, Inc. to SEC (Form 4). In total, 7 filings cover trades dated from 4 May 2022 to 28 June 2024.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 2 July 2024, the filings show a share grant in Medicine Man Technologies, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations